Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic neostigmine for prevention of postoperative ileus after radical cystectomy
IRCT20170826035911N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in postoperative ileus (POI) comparing Neostigmine prophylaxis with Placebo (2 arms). Primary endpoints: Age, Diversion type and 8 more. Started Mar 2025; status: completed.
02
Drugs
neostigmine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on IRCT20170826035911N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170826035911N2.